BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:47 PM
Mar 24, 2010
 |  BC Extra  |  Company News

EC approves DuoPlavin/DuoCover

The European Commission approved an MAA from Bristol-Myers Squibb Co. (NYSE:BMY) and sanofi-aventis Group...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >